Revive Therapeutics Announces Successful Research Results for OTF Psilocybin and Filing of U.S. Provisional Patent… Apr 22, 2021
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the… Apr 20, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
